Argenx Se (ARGX) Times Interest Earned (2019 - 2022)
Argenx Se (ARGX) posted quarterly Times Interest Earned of -$1383.9 for Q2 2022, up 100.0% year-on-year from -$691.96 in Q2 2021, and down 492.15% on a QoQ basis from -$233.71 in Q1 2022.
Argenx Se (ARGX) Times Interest Earned (2019 - 2022) Analysis & Trends
Argenx Se (ARGX) has reported Times Interest Earned for 3 consecutive years, with -$1383.9 the latest figure, recorded in Q2 2022.
- Quarterly Times Interest Earned rose 100.0% year-over-year to -$1383.9 in Q2 2022, while the trailing twelve-month figure through Mar 2023 was -$942.07 (up 100.0% YoY) and the FY2025 annual result came in at $258.16, up 3037.58% from the prior year.
- Times Interest Earned fell to -$1383.9 in Q2 2022 per ARGX's latest filing, from -$233.71 in the prior quarter.
- Over the last five years, Times Interest Earned for ARGX reached as high as $1286.6 in Q3 2019 and fell as low as -$11.0 billion in Q1 2021.
- A 3-year average of -$2.4 billion and a median of -$871.86 in 2019 frame the typical range for Times Interest Earned.
- The largest YoY upside for Times Interest Earned was 100.0% in 2022 against a maximum downside of 100.0% in 2022.
- Year by year, Times Interest Earned stood at -$359.8 in 2019, then slumped by 1015779453.03% to -$3.7 billion in 2021, then surged by 100.0% to -$1383.9 in 2022.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$1383.9, -$233.71, and -$3.7 billion for Q2 2022, Q1 2022, and Q2 2021 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Alnylam Pharmaceuticals | 35.71 Bn | 32.70 Bn | 959.66 Mn | 3.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -1,383.92 |
| Mar 31, 2022 | -233.71 |
| Jun 30, 2021 | -3.65 Bn |
| Mar 31, 2021 | -10.98 Bn |
| Dec 31, 2019 | -359.80 |
| Sep 30, 2019 | 1,286.55 |